atractylenolide-i has been researched along with Peritonitis* in 1 studies
1 other study(ies) available for atractylenolide-i and Peritonitis
Article | Year |
---|---|
Establishment of the model of white blood cell membrane chromatography and screening of antagonizing TLR4 receptor component from Atractylodes macrocephala Koidz.
A model of white blood cell membrane chromatography (WB-CMC) was established to screen active component from Atractylodes macrocephala Koidz. The component can antagonize Toll-like receptor 4 (TLR4) and inhibit inflammatory reaction. In the model of WB-CMC, cell membrane stationary phase (CMSP) was prepared by immobilizing the rabbit white blood cell membrane (WBCM) onto the surface of silica carrier and taxinol was used as a model molecule. The active component which can act on WBCM and its receptor (such as TLR4) as an effective target in A. macrocephala was determined by using a replacement experiment. The anti-inflammatory effects of the active component were tested by using pharmacological methods in vivo. The results indicated that the retention characteristics of atractylenolide I as active component was similar to that of taxinol in the model of WB-CMC. And so, atractylenolide I acted on the WBCM and TLR4 and its anti-inflammatory activity was related with antagonizing TLR4. Therefore, the interaction between the active component and WBCM and its receptor can be simulated by the model of WB-CMC in vitro. This model can be used to screen active components and to study effective characteristics for acting on definite targets. Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Atractylodes; Cell Membrane; Chromatography; Ear Diseases; Edema; Female; Lactones; Leukocytes; Male; Mice; Microscopy, Electron, Scanning; Peritonitis; Plant Extracts; Rabbits; Reproducibility of Results; Sesquiterpenes; Toll-Like Receptor 4; Xylenes | 2006 |